CGON CG Oncology, Inc.: institutional ownership and insider trading

248 funds reported holding $7.31B of CG Oncology, Inc. in their latest 13F filings; in Q2 2026 funds net bought $565M, with 33 new positions and 36 funds selling out; over the last 12 months insiders bought $24.8M and sold $4.83M on the open market; over its last four quarters it reported revenue of $6.23M and net income of −$224M.

CGON revenue and earnings

• Quarter ended Jun 30, 2026: revenue $1.16M, net income −$79.1M, EPS -0.90
• Quarter ended Mar 31, 2026: revenue $1.08M, net income −$60.2M, EPS -0.71
• Quarter ended Dec 31, 2025: revenue $2.32M, net income −$41.3M, EPS -0.52
• Quarter ended Sep 30, 2025: revenue $1.67M, net income −$43.8M, EPS -0.57

Famous investors holding CGON

• Ken Griffin (Citadel Advisors): $11.3M, 0.0% of the portfolio
• D. E. Shaw (D. E. Shaw & Co.): $6.35M, 0.0% of the portfolio
• Izzy Englander (Millennium Management): $1.42M, 0.0% of the portfolio

Largest institutional holders of CGON

1. RTW INVESTMENTS, LP — $605M
2. T. Rowe Price Investment Management, Inc. — $470M
3. Decheng Capital LLC — $453M
4. BlackRock, Inc. (BLK) — $445M
5. WELLINGTON MANAGEMENT GROUP LLP — $378M
6. FMR LLC — $296M
7. VANGUARD GROUP INC — $272M
8. PRICE T ROWE ASSOCIATES INC /MD/ — $270M
9. TCG Crossover Management, LLC — $261M
10. VANGUARD PORTFOLIO MANAGEMENT LLC — $246M

Recent CGON insider trades

• Oct 15, 2026: Post Leonard E sold 1,000 shares ($62.1K)
• Sep 15, 2026: Post Leonard E sold 1,000 shares ($73.0K)
• Aug 14, 2026: Post Leonard E sold 1,000 shares ($74.5K)
• Jul 15, 2026: Post Leonard E sold 1,000 shares ($71.2K)

5%+ owners

• RTW Investments, LP: 9.7% (Schedule 13G/A, filed Aug 14, 2026)
• T. Rowe Price Investment Management, Inc.: 8.0% (Schedule 13G, filed May 15, 2026)
• BlackRock, Inc.: 6.8% (Schedule 13G/A, filed Jul 27, 2026)
• Wellington Management Group LLP: 6.0% (Schedule 13G/A, filed Aug 13, 2026)

Who owns the most CGON stock?

The largest institutional holders of CG Oncology, Inc. in the latest 13F filings are RTW INVESTMENTS, LP ($605M), T. Rowe Price Investment Management, Inc. ($470M), Decheng Capital LLC ($453M).

Are insiders buying or selling CGON?

Over the last 12 months insiders bought $24.8M and sold $4.83M of CG Oncology, Inc. stock on the open market (SEC Form 4).

Which famous investors own CGON?

Ken Griffin, D. E. Shaw, Izzy Englander.

What was CGON's revenue last quarter?

CG Oncology, Inc. reported revenue of $1.16M for the quarter ended June 30, 2026, with net income of −$79.1M.

Which ETFs hold CGON?

73 ETFs and mutual funds hold it among their top 100 positions, including VGHAX, PACLX, XBI, PRJIX.

All CGON 13F holders · All CGON insider trades · CGON financials: revenue, earnings and balance sheet